Myrobalan Therapeutics
About:
Myrobalan Therapeutics is a biotech firm that develops oral neurorestorative therapies to reverse key brain dysfunctions and CNS conditions.
Website: https://myrotx.com
Top Investors: The ALS Association, Cowin Venture, 3E Bioventures, Guanzi Capital, AB Magnitude Ventures Group
Description:
Myro Therapeutics is a biotechnology company that focuses on the development of therapeutic solutions for Central Nervous System (CNS) disorders. The company's approach is rooted in a deep understanding of disease biology and mechanisms, which allows for the selection of targets that can effectively combat these disorders. Myro Therapeutics has a dedicated team of scientists who work tirelessly to advance the company's research and development efforts.
$33.4M
$10M to $50M
Medford, Massachusetts, United States
2021-01-01
info(AT)myrotx.com
Guoping Feng, Jing Wang, Zhigang He
11-50
2024-07-29
Private
© 2025 bioDAO.ai